Navigation Links
Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com September 11
Date:9/9/2014

NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo") the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today announced today that Keith Murphy, CEO, will present live at RetailInvestorConferences.com on September 11.

This event will be focused on updates and current information regarding Organovo and its business. For investors not yet familiar with the company and desire background, including an understanding of the 3D bioprinting used by Organovo to create functional living human tissues, investors can watch a different presentation that is already available by going now to the retain investor conferences site.

To view the background video, one can use these instructions now: http://retailinvestorconferences.com > red "register/ watch event now" button > 'presentations.'

To view the live update and current information presentation, use these instructions at the time indicated:
DATE: Thursday, September 11, 2014
TIME: 12:15 PM EDT
LINK: http://retailinvestorconferences.com  > red "register/ watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

Recent Company Highlights Include:

  • Key opinion leader reported Organovo's 3D Human Liver Tissue was able to establish the toxicity of toxic drug known to induce liver injury in humans that did not show toxicity in animal and other pre-clinical testing, an achievement historically unmet by animal models or other liver cell model systems
  • Initiated contracting for toxicity testing using its 3D Human Liver Tissue, for selected clients, in advance of its scheduled commercial release
  • Entered into additional agreements to utilize 3D bio-printed tissue in drug discovery settings
  • Reported that its 3D bio-printed tissues enabled researchers to make compartment-specific assessments (i.e., epithelium, stroma, vasculature) of drug response — something that is not currently possible outside of in vivo models to date
  • Announced an agreement with the University of Queensland directed toward development of source cell lines for 3D kidney tissue bioprinting activities
  • Appointed Gregory T. Lucier, former Chairman and CEO of Life Technologies, as a corporate advisor

About Organovo Holdings, Inc.

Organovo (NYSE MKT: ONVO) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, their technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com. Sign up for email updates and connect with us on Twitter (@Organovo).

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC), PRNewswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE Organovo Holdings, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Organovo Announces Appointment of Gregory T. Lucier as Corporate Advisor
2. Organovo Announces Collaboration with National Institutes of Health
3. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
4. Organovo Reports Q1 Fiscal 2014 Results, Provides Business Update
5. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
6. Organovo Announces the Nomination of Richard A. Heyman to Board of Directors
7. Organovo Rings Opening Bell On New York Stock Exchange
8. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
9. Organovo To List Common Stock On New York Stock Exchange MKT
10. Organovo Appoints Tamar D. Howson to Board of Directors
11. Organovo to Present at the 12th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography ... is estimated that 6.3 million Americans will have glaucoma, with black Americans having ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from ... documenting discrepancies between U.S. insurer policies for genetic testing and the 2019 National ... breast and ovarian cancer (HBOC). , Jill S. Dolinsky, director of ...
(Date:4/18/2019)... ... April 18, 2019 , ... Taking a ... includes a chemical engineer at Worcester Polytechnic Institute (WPI) has developed a novel ... possible to manufacture isobutanol and other biofuels more economically. , Isobutanol, like ethanol, ...
(Date:4/12/2019)... ... April 12, 2019 , ... An upcoming episode of ... about innovative tools and devices being used to enhance cognitive skills. This episode ... This segment of Advancements will focus on Sound for Life, a neurotechnology company ...
Breaking Biology Technology:
(Date:4/25/2019)... ... April 23, 2019 , ... Leak Detection Associates, ... Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is pleased to announce the ... New Jersey. The new facility was custom designed to meet enhanced manufacturing capabilities ...
(Date:4/25/2019)... ... April 24, 2019 , ... Noblis, Inc., a leading provider ... 10,191,929, “Systems and Methods for SNP Analysis and Genome Sequencing.” Noblis’ new system ... of advanced bioinformatic analyses, including SNP calling, metagenomic analysis, and conserved and signature ...
(Date:4/17/2019)... ... 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, Vice President ... Creating a Sustainable Global UDI Compliance Strategy at the European UDI Forum on 25 ... What device manufacturers did to comply with the US FDA UDI rule and ...
Breaking Biology News(10 mins):